These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38815168)

  • 21. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
    Mahal BA; Chen YW; Muralidhar V; Mahal AR; Choueiri TK; Hoffman KE; Hu JC; Sweeney CJ; Yu JB; Feng FY; Kim SP; Beard CJ; Martin NE; Trinh QD; Nguyen PL
    Ann Oncol; 2017 May; 28(5):1098-1104. PubMed ID: 28453693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications.
    Gershman B; Van Houten HK; Herrin J; Moreira DM; Kim SP; Shah ND; Karnes RJ
    Eur Urol; 2017 Jan; 71(1):55-65. PubMed ID: 26995328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.
    Howrey BT; Kuo YF; Lin YL; Goodwin JS
    J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):56-61. PubMed ID: 22562961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.
    Hayes JH; Barry MJ
    JAMA; 2014 Mar; 311(11):1143-9. PubMed ID: 24643604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
    Etzioni R; Berry KM; Legler JM; Shaw P
    Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men.
    Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R
    Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population screening for prostate cancer and emerging concepts for young men.
    Moul JW
    Clin Prostate Cancer; 2003 Sep; 2(2):87-97. PubMed ID: 15040869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baseline prostate-specific antigen testing at a young age.
    Loeb S; Carter HB; Catalona WJ; Moul JW; Schroder FH
    Eur Urol; 2012 Jan; 61(1):1-7. PubMed ID: 21862205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.
    Ross LE; Berkowitz Z; Ekwueme DU
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):636-44. PubMed ID: 18349281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient perspectives of prostate cancer screening vary by race following 2018 guideline changes.
    Riviere P; Kalavacherla S; Banegas MP; Javier-Desloges J; Martinez ME; Garraway IP; Murphy JD; Rose BS
    Cancer; 2023 Jan; 129(1):82-88. PubMed ID: 36345568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
    Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
    Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen testing among young men: an opportunity to improve value.
    Lange SM; Ambrose JP; Flynn MC; Lowrance WT; Hanson HA; O'Neil BB
    Cancer Med; 2021 Mar; 10(6):2075-2079. PubMed ID: 33626214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa.
    Maphayi MR; Cassim N; Bello B; George JA
    Pan Afr Med J; 2020; 35():61. PubMed ID: 32537065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
    Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
    Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate cancer screening in African American men: a review of the evidence.
    Kensler KH; Johnson R; Morley F; Albrair M; Dickerman BA; Gulati R; Holt SK; Iyer HS; Kibel AS; Lee JR; Preston MA; Vassy JL; Wolff EM; Nyame YA; Etzioni R; Rebbeck TR
    J Natl Cancer Inst; 2024 Jan; 116(1):34-52. PubMed ID: 37713266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.